Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Both studies continue to demonstrate no evidence of weight loss plateau
In a phase 1b trial, 20 weeks of cagrilintide 2.4 mg once weekly in combination with semaglutide 2.4 mg once weekly (cagrisema) resulted in up to 17.1% WL compared to 9.5% WL with semaglutide 2.4 mg plus placebo in people with obesity [88]
Enrollment was defined as randomization, with participants assigned within each cohort in a 6:2 ratio to receive PG-102 or a placebo
$90.99 Original price was: $90.99.$69.99Current price is: $69.99
US$ 27.00
US$ 22.27
US$ 29.50
US$ 22.31
US$ 24.17
US$ 21.25
US$ 23.64
US$ 21.64
US$ 23.41
US$ 27.21
